Vestibular Neuritis
12
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
Measuring Vestibular Organ Function With Weak Alternating Current Stimulation
Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?
Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis
Metabolic Disorders and Vertigo
MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla
The Efficacy of Steroid Therapy in Vestibular Neuritis
Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool
The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis